Development of a serum-free medium for in vitro expansion of human cytotoxic T lymphocytes using a statistical design

BMC Biotechnology

Volumn 10, Issue , 2010, Pages

  Jeon, Min K ^a   Lim, Jong Baeck ^b   Lee, Gyun M ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1-THIOGLYCEROL; 2-MERCAPTOETHANOL; BASAL MEDIUM; CELLULAR FUNCTION; CYTOTOXIC T LYMPHOCYTES; CYTOTOXICITY ASSAYS; DENDRITIC CELLS; ETHANOLAMINES; FERRIC CITRATE; FETAL BOVINE SERUM; FRACTIONAL FACTORIALS; HUMAN LYMPHOCYTES; IN-VITRO; OPTIMAL CONCENTRATION; PERIPHERAL BLOOD MONONUCLEAR CELLS; POLYAMINES; PYRUVATES; RESPONSE SURFACE METHOD; SERUM-FREE MEDIUM; STATISTICAL ANALYSIS; STATISTICAL DESIGN; STATISTICAL OPTIMIZATION; VIABLE CELLS;

AMINO ACIDS; BODY FLUIDS; CELL GROWTH; CHOLESTEROL; CONCENTRATION (PROCESS); CYTOTOXICITY; FATTY ACIDS; GROWTH KINETICS; OPTIMIZATION; SODIUM; SURFACE PROPERTIES;

CELL CULTURE;

ALBUMIN; ALPHA THIOGLYCEROL; CD14 ANTIGEN; CD19 ANTIGEN; CHOLESTEROL; ETHANOLAMINE; FATTY ACID; FERRIC CITRATE; GLUTAMINE; GLYCEROL DERIVATIVE; INSULIN; MERCAPTOETHANOL; NONESSENTIAL AMINO ACID; POLYAMINE; PYRUVATE SODIUM; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL GROWTH; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; DENDRITIC CELL; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; STATISTICAL ANALYSIS; SURFACE PROPERTY; CHEMISTRY; COMPUTER PROGRAM; CULTURE TECHNIQUE; CYTOLOGY; FACTORIAL ANALYSIS;

BOVINAE;

CELL CULTURE TECHNIQUES; CULTURE MEDIA, SERUM-FREE; FACTOR ANALYSIS, STATISTICAL; HUMANS; SOFTWARE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77956660526     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-10-70     Document Type: Article

References (31)

1. Lim JB, Kwon OH, Kim HS, Kim HO, Choi JR, Provenzano M, Stroncek D. Adoptive immunotherapy for cytomegalovirus (CMV) disease in immunocompromised patients. Yonsei Med J 2004, 45(Suppl):18-22.
2. Powell DJ, Levine BL. Adoptive T-cell therapy for malignant disorders. Haematologica 2008, 93:1452-1456. 10.3324/haematol.13717, 18827263.
3. van Rhee F, Barrett J. Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation. Cytotherapy 2002, 4:3-10. 10.1080/146532402317251473, 11953036.
4. Foster AE, Gottlieb DJ, Marangolo M, Bartlett A, Li YC, Barton GW, Romagnoli JA, Bradstock KF. Rapid, large-scale generation of highly pure cytomegalovirus-specific cytotoxic T cells for adoptive immunotherapy. J Hematother Stem Cell Res 2003, 12:93-105. 10.1089/152581603321210172, 12662440.
5. Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, Riddell SR. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995, 333:1038-1044. 10.1056/NEJM199510193331603, 7675046.
6. Cooper LJ, Ausubel L, Gutierrez M, Stephan S, Shakeley R, Olivares S, Serrano LM, Burton L, Jensen MC, Forman SJ, DiGiusto DL. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma. Cytotherapy 2006, 8:105-117. 10.1080/14653240600620176, 16698684.
7. Foster AE, Forrester K, Gottlieb DJ, Barton GW, Romagnoli JA, Bradstock KF. Large-scale expansion of cytomegalovirus-specific cytotoxic T cells in suspension culture. Biotechnol Bioeng 2004, 85:138-146. 10.1002/bit.10801, 14704996.
8. Yssel H, De Vries JE, Koken M, Van Blitterswijk W, Spits H. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J Immunol Methods 1984, 72:219-227. 10.1016/0022-1759(84)90450-2, 6086760.
9. Goodman MG, Weigle WO. Nonspecific activation of murine lymphocytes. I. Proliferation and polyclonal activation induced by 2-mercaptoethanol and alpha-thioglycerol. J Exp Med 1977, 145:473-489. 10.1084/jem.145.3.473, 2180719, 233897.
10. Polet H, Spieker-Polet H. Serum albumin is essential for in vitro growth of activated human lymphocytes. J Exp Med 1975, 142:949-959. 10.1084/jem.142.4.949, 2189952, 1176892.
11. Bottenstein JE, Sato GH. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 1979, 76:514-517. 10.1073/pnas.76.1.514, 382972, 284369.
12. Fujii DK, Cheng J, Gospodarowicz D. Phosphatidyl choline and the growth in serum-free medium of vascular endothelial and smooth muscle cells, and corneal endothelial cells. J Cell Physiol 1983, 114:267-278. 10.1002/jcp.1041140304, 6833402.
13. Haeffner EW, Hoffmann CJ, Stoehr M, Scherf H. Cholesterol-induced growth stimulation, cell aggregation, and membrane properties of ascites tumor cells in culture. Cancer Res 1984, 44:2668-2676.
14. Sandadi S, Ensari S, Kearns B. Application of fractional factorial designs to screen active factors for antibody production by chinese hamster ovary cells. Biotechnol Prog 2006, 22:595-600. 10.1021/bp050300q, 16599582.
15. McLaughlin-Taylor E, Pande H, Forman SJ, Tanamachi B, Li CR, Zaia JA, Greenberg PD, Riddell SR. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol 1994, 43:103-110. 10.1002/jmv.1890430119, 8083644.
16. Solache A, Morgan CL, Dodi AI, Morte C, Scott I, Baboonian C, Zal B, Goldman J, Grundy JE, Madrigal JA. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. J Immunol 1999, 163:5512-5518.
17. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B, Sissons JG. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996, 70:7569-7579. 190825, 8892876.
18. Stamatis DH. Six sigma and beyond: Design of experiments 2001, Boca Raton, FL: St. Lucie Press.
19. Martinuzzi E, Scotto M, Enee E, Brezar V, Ribeil JA, van Endert P, Mallone R. Serum-free culture medium and IL-7 costimulation increase the sensitivity of ELISpot detection. J Immunol Methods 2008, 333:61-70. 10.1016/j.jim.2008.01.003, 18242633.
20. Xu F, Rychnovsky SD, Belani JD, Hobbs HH, Cohen JC, Rawson RB. Dual roles for cholesterol in mammalian cells. P Natl Acad Sci USA 2005, 102:14551-14556.
21. Albrecht I, Gatfield J, Mini T, Jeno P, Pieters J. Essential role for cholesterol in the delivery of exogenous antigens to the MHC class I-presentation pathway. Int Immunol 2006, 18:755-765. 10.1093/intimm/dxl013, 16608901.
22. Sandstrom CE, Miller WM, Papoutsakis ET. Serum-free media for cultures of primitive and mature hematopoietic cells. Biotechnol Bioeng 1994, 43:706-733. 10.1002/bit.260430806, 18615795.
23. Cuadrado A, Carnero A, Dolfi F, Jimenez B, Lacal JC. Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors. Oncogene 1993, 8:2959-2968.
24. Caselli E, Baricordi OR, Melchiorri L, Bellini F, Ponzin D, Bruni A. Inhibition of DNA synthesis in peripheral blood mononuclear cells treated with phosphatidylserines containing unsaturated acyl chains. Immunopharmacology 1992, 23:205-213. 10.1016/0162-3109(92)90027-A, 1500286.
25. Kremlev SG, Umstead TM, Phelps DS. Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am J Physiol 1994, 267:L357-364.
26. Nishiyama-Naruke A, Curi R. Phosphatidylcholine participates in the interaction between macrophages and lymphocytes. Am J Physiol Cell Physiol 2000, 278:C554-560.
27. Al-Shanti N, Aldahoudi Z. Human purified CD8+ T cells: Ex vivo expansion model to generate a maximum yield of functional cytotoxic cells. Immunol Invest 2007, 36:85-104. 10.1080/08820130600991950, 17190652.
28. Lim JB, Provenzano M, Kwon OH, Bettinotti M, Caruccio L, Nagorsen D, Stroncek D. Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes. Exp Hematol 2006, 34:296-307. 10.1016/j.exphem.2005.12.006, 16543064.
29. Herr W, Schneider J, Lohse AW, Meyer zum Buschenfelde KH, Wolfel T. Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens. J Immunol Methods 1996, 191:131-142. 10.1016/0022-1759(96)00007-5, 8666832.
30. Kleihauer A, Grigoleit U, Hebart H, Moris A, Brossart P, Muhm A, Stevanovic S, Rammensee HG, Sinzger C, Riegler S, Jahn G, Kanz L, Einsele H. Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells. Br J Haematol 2001, 113:231-239. 10.1046/j.1365-2141.2001.02681.x, 11328306.
31. Metes D, Storkus W, Zeevi A, Patterson K, Logar A, Rowe D, Nalesnik MA, Fung JJ, Rao AS. Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals. Transplantation 2000, 70:1507-1515. 10.1097/00007890-200011270-00019, 11118098.